Glenmede Trust’s VivoSim Labs VIVS Stock Holding History

Glenmede Trust’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1	Closed	–	–	2313
2020 Q3	$0	Hold	1	–	–	﹤0.01%	2603
2020 Q2	$0	Hold	1	–	–	﹤0.01%	2644
2020 Q1	$0	Hold	1	–	–	﹤0.01%	3073
2019 Q4	$0	Hold	1	–	–	﹤0.01%	3148
2019 Q3	$0	Hold	1	–	–	﹤0.01%	3145
2019 Q2	$0	Hold	1	–	–	﹤0.01%	3199
2019 Q1	$0	Hold	1	–	–	﹤0.01%	3203
2018 Q4	$0	Buy	+1	New	+$252	﹤0.01%	3102
2017 Q4	–	Sell	-5	Closed	-$2K	–	2816
2017 Q3	$2K	Hold	5	–	–	﹤0.01%	2602
2017 Q2	$3K	Hold	5	–	–	﹤0.01%	2428
2017 Q1	$3K	Hold	5	–	–	﹤0.01%	2428
2016 Q4	$4K	Hold	5	–	–	﹤0.01%	2281
2016 Q3	$4K	Hold	5	–	–	﹤0.01%	2314
2016 Q2	$4K	Hold	5	–	–	﹤0.01%	2291
2016 Q1	$2K	Hold	5	–	–	﹤0.01%	2426
2015 Q4	$3K	Hold	5	–	–	﹤0.01%	2403
2015 Q3	$3K	Hold	5	–	–	﹤0.01%	2438
2015 Q2	$4K	Sell	5 -4	-44%	-$4.47K	﹤0.01%	2304
2015 Q1	$7K	Hold	9	–	–	﹤0.01%	2194
2014 Q4	$16K	Hold	9	–	–	﹤0.01%	2082
2014 Q3	$14K	Hold	9	–	–	﹤0.01%	2043
2014 Q2	$18K	Hold	9	–	–	﹤0.01%	1891
2014 Q1	$17K	Hold	9	–	–	﹤0.01%	1923
2013 Q4	$24K	Buy	9 +5	+125%	+$9.81K	﹤0.01%	1807
2013 Q3	$5K	Buy	+4	New	+$5.59K	﹤0.01%	2056

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Glenmede Trust's VIVS Position: Q4 2020 in Review

Glenmede Trust sold out of VivoSim Labs (VIVS) in Q4 2020, closing a stake of 1 share.

Glenmede Trust first reported a position in VIVS in Q3 2013 and held it in 25 quarters. The position peaked at $24K in Q4 2013. 46 funds tracked by Wall St. Rank hold VIVS as of Q4 2020.

Glenmede Trust reported no remaining VivoSim Labs position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 1 VivoSim Labs share in Q4 2020.
Glenmede Trust first reported a position in VivoSim Labs in Q3 2013 and held it in 25 quarters.
Glenmede Trust's VivoSim Labs position peaked at $24K in Q4 2013.
46 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.